CN103861017B - 用于治疗结核性胸腔积液的中药组合物及其制备方法 - Google Patents
用于治疗结核性胸腔积液的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN103861017B CN103861017B CN201410145260.8A CN201410145260A CN103861017B CN 103861017 B CN103861017 B CN 103861017B CN 201410145260 A CN201410145260 A CN 201410145260A CN 103861017 B CN103861017 B CN 103861017B
- Authority
- CN
- China
- Prior art keywords
- weight portion
- weight portions
- weight
- root
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 83
- 239000000203 mixture Substances 0.000 title claims abstract description 60
- 208000002151 Pleural effusion Diseases 0.000 title claims abstract description 46
- 238000002360 preparation method Methods 0.000 title claims abstract description 22
- 210000000582 semen Anatomy 0.000 claims abstract description 32
- 239000000463 material Substances 0.000 claims abstract description 30
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 27
- 241001165494 Rhodiola Species 0.000 claims abstract description 25
- 241000132012 Atractylodes Species 0.000 claims abstract description 23
- 239000009636 Huang Qi Substances 0.000 claims abstract description 23
- 235000009076 Phytolacca acinosa Nutrition 0.000 claims abstract description 22
- 240000008013 Phytolacca acinosa Species 0.000 claims abstract description 22
- 235000004338 Syringa vulgaris Nutrition 0.000 claims abstract description 22
- 235000016641 Syzygium paniculatum Nutrition 0.000 claims abstract description 22
- 244000223082 Syzygium paniculatum Species 0.000 claims abstract description 22
- 240000008042 Zea mays Species 0.000 claims abstract description 22
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 22
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 22
- 235000005822 corn Nutrition 0.000 claims abstract description 22
- 235000011274 Benincasa cerifera Nutrition 0.000 claims abstract description 21
- 244000036905 Benincasa cerifera Species 0.000 claims abstract description 21
- 240000006248 Broussonetia kazinoki Species 0.000 claims abstract description 21
- 241000218378 Magnolia Species 0.000 claims abstract description 21
- 241000756943 Codonopsis Species 0.000 claims abstract description 20
- 244000077995 Coix lacryma jobi Species 0.000 claims abstract description 19
- 244000197580 Poria cocos Species 0.000 claims abstract description 18
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 18
- 240000004307 Citrus medica Species 0.000 claims abstract description 17
- 241001116389 Aloe Species 0.000 claims abstract description 14
- 235000011399 aloe vera Nutrition 0.000 claims abstract description 14
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims abstract description 7
- 244000297179 Syringa vulgaris Species 0.000 claims abstract description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 93
- 239000000284 extract Substances 0.000 claims description 36
- 239000006210 lotion Substances 0.000 claims description 32
- 239000007788 liquid Substances 0.000 claims description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 22
- 239000000047 product Substances 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 17
- 239000000843 powder Substances 0.000 claims description 17
- 238000012545 processing Methods 0.000 claims description 15
- 238000001914 filtration Methods 0.000 claims description 13
- 238000010992 reflux Methods 0.000 claims description 12
- 230000002829 reductive effect Effects 0.000 claims description 9
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 8
- 229930006000 Sucrose Natural products 0.000 claims description 8
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 8
- 229910052799 carbon Inorganic materials 0.000 claims description 8
- 239000006071 cream Substances 0.000 claims description 8
- 230000008569 process Effects 0.000 claims description 8
- 238000011084 recovery Methods 0.000 claims description 8
- 239000011265 semifinished product Substances 0.000 claims description 8
- 229960004793 sucrose Drugs 0.000 claims description 8
- 229920002472 Starch Polymers 0.000 claims description 6
- 238000009472 formulation Methods 0.000 claims description 6
- 239000008107 starch Substances 0.000 claims description 6
- 235000019698 starch Nutrition 0.000 claims description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 5
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 4
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 4
- 239000000706 filtrate Substances 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 4
- 239000008101 lactose Substances 0.000 claims description 4
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 4
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 4
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 4
- 239000008194 pharmaceutical composition Substances 0.000 claims description 4
- 238000001556 precipitation Methods 0.000 claims description 4
- 238000005057 refrigeration Methods 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 4
- 238000003860 storage Methods 0.000 claims description 4
- 235000020985 whole grains Nutrition 0.000 claims description 4
- 238000010790 dilution Methods 0.000 claims 1
- 239000012895 dilution Substances 0.000 claims 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N ferric oxide Chemical compound O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 50
- 206010030113 Oedema Diseases 0.000 abstract description 43
- 210000004369 blood Anatomy 0.000 abstract description 28
- 239000008280 blood Substances 0.000 abstract description 28
- 208000004880 Polyuria Diseases 0.000 abstract description 23
- 230000035619 diuresis Effects 0.000 abstract description 23
- 230000001737 promoting effect Effects 0.000 abstract description 13
- 230000001939 inductive effect Effects 0.000 abstract description 11
- 230000008901 benefit Effects 0.000 abstract description 10
- 230000017531 blood circulation Effects 0.000 abstract description 9
- 230000009286 beneficial effect Effects 0.000 abstract description 6
- 231100000957 no side effect Toxicity 0.000 abstract description 4
- 210000000952 spleen Anatomy 0.000 description 44
- 210000003734 kidney Anatomy 0.000 description 29
- 210000004072 lung Anatomy 0.000 description 28
- 230000006870 function Effects 0.000 description 27
- 210000000038 chest Anatomy 0.000 description 26
- 235000009508 confectionery Nutrition 0.000 description 25
- 235000019640 taste Nutrition 0.000 description 24
- 201000010099 disease Diseases 0.000 description 23
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 23
- 206010011224 Cough Diseases 0.000 description 20
- 230000007812 deficiency Effects 0.000 description 18
- 210000004185 liver Anatomy 0.000 description 18
- 210000002784 stomach Anatomy 0.000 description 18
- 206010062717 Increased upper airway secretion Diseases 0.000 description 17
- 241001104043 Syringa Species 0.000 description 17
- 208000026435 phlegm Diseases 0.000 description 17
- 208000002193 Pain Diseases 0.000 description 16
- 241000699666 Mus <mouse, genus> Species 0.000 description 14
- 229940079593 drug Drugs 0.000 description 14
- 239000012530 fluid Substances 0.000 description 14
- 230000036407 pain Effects 0.000 description 14
- 230000004087 circulation Effects 0.000 description 12
- 101710169336 5'-deoxyadenosine deaminase Proteins 0.000 description 11
- 102000055025 Adenosine deaminases Human genes 0.000 description 11
- 208000024891 symptom Diseases 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- 210000002216 heart Anatomy 0.000 description 10
- 210000004224 pleura Anatomy 0.000 description 10
- 206010012735 Diarrhoea Diseases 0.000 description 9
- 210000003205 muscle Anatomy 0.000 description 9
- 241000345998 Calamus manan Species 0.000 description 8
- 241001166575 Carex platyphylla Species 0.000 description 8
- 241000521257 Hydrops Species 0.000 description 8
- 244000303847 Lagenaria vulgaris Species 0.000 description 8
- 235000009797 Lagenaria vulgaris Nutrition 0.000 description 8
- 210000000988 bone and bone Anatomy 0.000 description 8
- 230000002401 inhibitory effect Effects 0.000 description 8
- 235000012950 rattan cane Nutrition 0.000 description 8
- 230000008673 vomiting Effects 0.000 description 8
- 208000006820 Arthralgia Diseases 0.000 description 7
- 241000193830 Bacillus <bacterium> Species 0.000 description 7
- 241000282414 Homo sapiens Species 0.000 description 7
- 206010047700 Vomiting Diseases 0.000 description 7
- 238000003304 gavage Methods 0.000 description 7
- 241000411851 herbal medicine Species 0.000 description 7
- 201000001881 impotence Diseases 0.000 description 7
- 230000035922 thirst Effects 0.000 description 7
- 210000003932 urinary bladder Anatomy 0.000 description 7
- 206010007247 Carbuncle Diseases 0.000 description 6
- 206010010774 Constipation Diseases 0.000 description 6
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 6
- 208000002894 beriberi Diseases 0.000 description 6
- 230000036772 blood pressure Effects 0.000 description 6
- AEUTYOVWOVBAKS-UWVGGRQHSA-N ethambutol Chemical compound CC[C@@H](CO)NCCN[C@@H](CC)CO AEUTYOVWOVBAKS-UWVGGRQHSA-N 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 210000003127 knee Anatomy 0.000 description 6
- 210000002429 large intestine Anatomy 0.000 description 6
- 239000002398 materia medica Substances 0.000 description 6
- 231100000252 nontoxic Toxicity 0.000 description 6
- 230000003000 nontoxic effect Effects 0.000 description 6
- 231100000614 poison Toxicity 0.000 description 6
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 6
- 229960001225 rifampicin Drugs 0.000 description 6
- 210000000115 thoracic cavity Anatomy 0.000 description 6
- 210000002700 urine Anatomy 0.000 description 6
- 235000014101 wine Nutrition 0.000 description 6
- 206010000060 Abdominal distension Diseases 0.000 description 5
- 208000000059 Dyspnea Diseases 0.000 description 5
- 206010013975 Dyspnoeas Diseases 0.000 description 5
- 241000283973 Oryctolagus cuniculus Species 0.000 description 5
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 5
- 208000019790 abdominal distention Diseases 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- 206010003549 asthenia Diseases 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 210000000481 breast Anatomy 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 230000003203 everyday effect Effects 0.000 description 5
- 210000003414 extremity Anatomy 0.000 description 5
- 210000000936 intestine Anatomy 0.000 description 5
- QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 description 5
- 231100000862 numbness Toxicity 0.000 description 5
- 238000010791 quenching Methods 0.000 description 5
- 208000011580 syndromic disease Diseases 0.000 description 5
- 244000025254 Cannabis sativa Species 0.000 description 4
- 206010063045 Effusion Diseases 0.000 description 4
- 206010048612 Hydrothorax Diseases 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 206010033799 Paralysis Diseases 0.000 description 4
- 241000405414 Rehmannia Species 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 206010003246 arthritis Diseases 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 230000035876 healing Effects 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 201000004792 malaria Diseases 0.000 description 4
- 230000027939 micturition Effects 0.000 description 4
- 230000000171 quenching effect Effects 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 208000007848 Alcoholism Diseases 0.000 description 3
- 241000208340 Araliaceae Species 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 102000009123 Fibrin Human genes 0.000 description 3
- 108010073385 Fibrin Proteins 0.000 description 3
- 206010022998 Irritability Diseases 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 206010038743 Restlessness Diseases 0.000 description 3
- 241000191940 Staphylococcus Species 0.000 description 3
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 3
- 206010045104 Tuberculous pleurisy Diseases 0.000 description 3
- 208000037386 Typhoid Diseases 0.000 description 3
- 208000000260 Warts Diseases 0.000 description 3
- 208000031971 Yin Deficiency Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 206010000496 acne Diseases 0.000 description 3
- 201000007930 alcohol dependence Diseases 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- 150000003797 alkaloid derivatives Chemical class 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000002365 anti-tubercular Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 230000001077 hypotensive effect Effects 0.000 description 3
- 238000010253 intravenous injection Methods 0.000 description 3
- 201000007227 lymph node tuberculosis Diseases 0.000 description 3
- 210000004698 lymphocyte Anatomy 0.000 description 3
- 230000002175 menstrual effect Effects 0.000 description 3
- 210000001616 monocyte Anatomy 0.000 description 3
- 231100000915 pathological change Toxicity 0.000 description 3
- 230000036285 pathological change Effects 0.000 description 3
- 201000010098 pleural tuberculosis Diseases 0.000 description 3
- 230000007096 poisonous effect Effects 0.000 description 3
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000000717 retained effect Effects 0.000 description 3
- 229930182490 saponin Natural products 0.000 description 3
- 150000007949 saponins Chemical class 0.000 description 3
- 201000010153 skin papilloma Diseases 0.000 description 3
- 239000002689 soil Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 229960001005 tuberculin Drugs 0.000 description 3
- 201000008297 typhoid fever Diseases 0.000 description 3
- 210000001113 umbilicus Anatomy 0.000 description 3
- WVTKBKWTSCPRNU-KYJUHHDHSA-N (+)-Tetrandrine Chemical compound C([C@H]1C=2C=C(C(=CC=2CCN1C)OC)O1)C(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2C[C@@H]2N(C)CCC3=CC(OC)=C(OC)C1=C23 WVTKBKWTSCPRNU-KYJUHHDHSA-N 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- YDQWDHRMZQUTBA-UHFFFAOYSA-N Aloe emodin Chemical compound C1=CC=C2C(=O)C3=CC(CO)=CC(O)=C3C(=O)C2=C1O YDQWDHRMZQUTBA-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 2
- 206010003445 Ascites Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000304886 Bacilli Species 0.000 description 2
- 241000255789 Bombyx mori Species 0.000 description 2
- 206010008479 Chest Pain Diseases 0.000 description 2
- 241000723369 Cocculus trilobus Species 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 2
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 208000037093 Menstruation Disturbances Diseases 0.000 description 2
- 206010027339 Menstruation irregular Diseases 0.000 description 2
- 206010062575 Muscle contracture Diseases 0.000 description 2
- 241000590428 Panacea Species 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 241000588769 Proteus <enterobacteria> Species 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 241000607764 Shigella dysenteriae Species 0.000 description 2
- 208000001203 Smallpox Diseases 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 241001369613 Stephania tetrandra Species 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 208000002474 Tinea Diseases 0.000 description 2
- 241000130764 Tinea Species 0.000 description 2
- 241000870995 Variola Species 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 238000011047 acute toxicity test Methods 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- VIROVYVQCGLCII-UHFFFAOYSA-N amobarbital Chemical compound CC(C)CCC1(CC)C(=O)NC(=O)NC1=O VIROVYVQCGLCII-UHFFFAOYSA-N 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 150000004056 anthraquinones Chemical class 0.000 description 2
- 230000002929 anti-fatigue Effects 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- 230000003356 anti-rheumatic effect Effects 0.000 description 2
- 239000002221 antipyretic Substances 0.000 description 2
- 239000003435 antirheumatic agent Substances 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 238000004380 ashing Methods 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- LQGUBLBATBMXHT-UHFFFAOYSA-N chrysophanol Chemical compound C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 208000006111 contracture Diseases 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 229940030606 diuretics Drugs 0.000 description 2
- 208000017574 dry cough Diseases 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 229960000285 ethambutol Drugs 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 229950003499 fibrin Drugs 0.000 description 2
- 206010016766 flatulence Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 150000008131 glucosides Chemical class 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 238000010255 intramuscular injection Methods 0.000 description 2
- 239000007927 intramuscular injection Substances 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 2
- 201000005630 leukorrhea Diseases 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 230000008855 peristalsis Effects 0.000 description 2
- 210000003281 pleural cavity Anatomy 0.000 description 2
- 208000008423 pleurisy Diseases 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 238000010079 rubber tapping Methods 0.000 description 2
- 239000004576 sand Substances 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- IPQVTOJGNYVQEO-CXZNLNCXSA-N sennoside A Natural products O=C(O)c1cc(O)c2C(=O)c3c(O[C@H]4[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O4)cccc3[C@@H]([C@H]3c4c(c(O)cc(C(=O)O)c4)C(=O)c4c(O[C@H]5[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O5)cccc34)c2c1 IPQVTOJGNYVQEO-CXZNLNCXSA-N 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 229940007046 shigella dysenteriae Drugs 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 239000003760 tallow Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 201000002327 urinary tract obstruction Diseases 0.000 description 2
- 206010046901 vaginal discharge Diseases 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000242 Abortion threatened Diseases 0.000 description 1
- 244000167222 Acanthopanax sessiliflorus Species 0.000 description 1
- 235000017615 Acanthopanax sessiliflorus Nutrition 0.000 description 1
- 241000208140 Acer Species 0.000 description 1
- 206010049865 Achromotrichia acquired Diseases 0.000 description 1
- 241000173529 Aconitum napellus Species 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 208000000884 Airway Obstruction Diseases 0.000 description 1
- 108010053754 Aldehyde reductase Proteins 0.000 description 1
- 102100027265 Aldo-keto reductase family 1 member B1 Human genes 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000004300 Atrophic Gastritis Diseases 0.000 description 1
- 201000008283 Atrophic Rhinitis Diseases 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 241001037822 Bacillus bacterium Species 0.000 description 1
- 241001647745 Banksia Species 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 241000588807 Bordetella Species 0.000 description 1
- 208000002381 Brain Hypoxia Diseases 0.000 description 1
- 206010053481 Bronchopleural fistula Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010007027 Calculus urinary Diseases 0.000 description 1
- 235000008671 Calycanthus floridus Nutrition 0.000 description 1
- 244000025311 Calycanthus occidentalis Species 0.000 description 1
- 235000008670 Calycanthus occidentalis Nutrition 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 241000050051 Chelone glabra Species 0.000 description 1
- 239000003390 Chinese drug Substances 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010009192 Circulatory collapse Diseases 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 241000209205 Coix Species 0.000 description 1
- 235000007354 Coix lacryma jobi Nutrition 0.000 description 1
- 206010009900 Colitis ulcerative Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 235000002991 Coptis groenlandica Nutrition 0.000 description 1
- 244000247747 Coptis groenlandica Species 0.000 description 1
- 241000220284 Crassulaceae Species 0.000 description 1
- 244000265913 Crataegus laevigata Species 0.000 description 1
- 235000013175 Crataegus laevigata Nutrition 0.000 description 1
- INYYVPJSBIVGPH-VLXJIEOASA-N Cucoline Natural products C([C@H]1N(CC2)C)C3=CC=C(OC)C(O)=C3[C@@]32[C@@H]1C=C(OC)C(=O)C3 INYYVPJSBIVGPH-VLXJIEOASA-N 0.000 description 1
- 241000256059 Culex pipiens Species 0.000 description 1
- 244000301850 Cupressus sempervirens Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 101100276976 Drosophila melanogaster Drak gene Proteins 0.000 description 1
- 241000092728 Eleutherococcus gracilistylus Species 0.000 description 1
- 101100379079 Emericella variicolor andA gene Proteins 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000004929 Facial Paralysis Diseases 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 101710145505 Fiber protein Proteins 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 208000001034 Frostbite Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 240000004859 Gamochaeta purpurea Species 0.000 description 1
- 208000012895 Gastric disease Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000036495 Gastritis atrophic Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010018366 Glomerulonephritis acute Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 241000606768 Haemophilus influenzae Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 208000004356 Hysteria Diseases 0.000 description 1
- 206010021718 Induced labour Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 235000004520 Lindera benzoin Nutrition 0.000 description 1
- 235000008262 Lindera benzoin var. benzoin Nutrition 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 206010026673 Malignant Pleural Effusion Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010056677 Nerve degeneration Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- 241000009328 Perro Species 0.000 description 1
- 206010035603 Pleural mesothelioma Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 235000014258 Polygonum bistorta Nutrition 0.000 description 1
- 244000233952 Polygonum bistorta Species 0.000 description 1
- 241000168036 Populus alba Species 0.000 description 1
- 240000004064 Poterium sanguisorba Species 0.000 description 1
- 235000008291 Poterium sanguisorba Nutrition 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 206010064715 Reexpansion pulmonary oedema Diseases 0.000 description 1
- 208000037656 Respiratory Sounds Diseases 0.000 description 1
- 240000004980 Rheum officinale Species 0.000 description 1
- 235000008081 Rheum officinale Nutrition 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 206010039088 Rhinitis atrophic Diseases 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 241000569285 Sabia japonica Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000008282 Sanguisorba officinalis Nutrition 0.000 description 1
- INYYVPJSBIVGPH-QHRIQVFBSA-N Sinomenine Chemical compound C([C@@H]1N(CC2)C)C3=CC=C(OC)C(O)=C3[C@@]32[C@@H]1C=C(OC)C(=O)C3 INYYVPJSBIVGPH-QHRIQVFBSA-N 0.000 description 1
- 241001643409 Sinomenium acutum Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 241000193996 Streptococcus pyogenes Species 0.000 description 1
- 206010042241 Stridor Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 235000005865 Symphytum officinale Nutrition 0.000 description 1
- 240000002299 Symphytum officinale Species 0.000 description 1
- 235000003337 Symplocos paniculata Nutrition 0.000 description 1
- 244000022370 Symplocos paniculata Species 0.000 description 1
- 241000120020 Tela Species 0.000 description 1
- IOYNQIMAUDJVEI-BMVIKAAMSA-N Tepraloxydim Chemical group C1C(=O)C(C(=N/OC\C=C\Cl)/CC)=C(O)CC1C1CCOCC1 IOYNQIMAUDJVEI-BMVIKAAMSA-N 0.000 description 1
- 241000270708 Testudinidae Species 0.000 description 1
- 208000003217 Tetany Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000005985 Threatened Abortion Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 208000009596 Tooth Mobility Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 201000006704 Ulcerative Colitis Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 208000036826 VIIth nerve paralysis Diseases 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- AMMHDXLWLCQPML-UHFFFAOYSA-N [Na].N1(C)C(=O)N(C)C=2N=CN(C)C2C1=O Chemical compound [Na].N1(C)C(=O)N(C)C=2N=CN(C)C2C1=O AMMHDXLWLCQPML-UHFFFAOYSA-N 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 231100000851 acute glomerulonephritis Toxicity 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229960001301 amobarbital Drugs 0.000 description 1
- 238000001949 anaesthesia Methods 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000031016 anaphase Effects 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001760 anti-analgesic effect Effects 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000002082 anti-convulsion Effects 0.000 description 1
- 230000003509 anti-fertility effect Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 229940065181 bacillus anthracis Drugs 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 201000003433 benign pleural mesothelioma Diseases 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 208000034526 bruise Diseases 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000035568 catharsis Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000011976 chest X-ray Methods 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- CYDMQBQPVICBEU-UHFFFAOYSA-N chlorotetracycline Natural products C1=CC(Cl)=C2C(O)(C)C3CC4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-UHFFFAOYSA-N 0.000 description 1
- CYDMQBQPVICBEU-XRNKAMNCSA-N chlortetracycline Chemical compound C1=CC(Cl)=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-XRNKAMNCSA-N 0.000 description 1
- 229960004475 chlortetracycline Drugs 0.000 description 1
- 235000019365 chlortetracycline Nutrition 0.000 description 1
- 230000002279 cholagogic effect Effects 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 208000016644 chronic atrophic gastritis Diseases 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- NZPQWZZXRKZCDU-UHFFFAOYSA-N chrysophanol Natural products Cc1cc(O)c2C(=O)c3c(O)cccc3Oc2c1 NZPQWZZXRKZCDU-UHFFFAOYSA-N 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 210000000795 conjunctiva Anatomy 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 229940072185 drug for treatment of tuberculosis Drugs 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- -1 flavone compound Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 208000027692 gas pain Diseases 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000002641 glycemic effect Effects 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000010247 heart contraction Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000007475 hemolytic anemia Diseases 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000023513 hiccough Diseases 0.000 description 1
- 230000036732 histological change Effects 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 208000016290 incoordination Diseases 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 244000000053 intestinal parasite Species 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 229960003350 isoniazid Drugs 0.000 description 1
- 229910052622 kaolinite Inorganic materials 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 208000024765 knee pain Diseases 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 210000004324 lymphatic system Anatomy 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- RMCMHUFPMHONOO-UHFFFAOYSA-N methyl 2-(aminomethyl)benzoate;hydrochloride Chemical compound Cl.COC(=O)C1=CC=CC=C1CN RMCMHUFPMHONOO-UHFFFAOYSA-N 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000020825 overweight Nutrition 0.000 description 1
- 238000003359 percent control normalization Methods 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000000505 pernicious effect Effects 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- WVTKBKWTSCPRNU-UHFFFAOYSA-N rac-Tetrandrin Natural products O1C(C(=CC=2CCN3C)OC)=CC=2C3CC(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2CC2N(C)CCC3=CC(OC)=C(OC)C1=C23 WVTKBKWTSCPRNU-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229910052957 realgar Inorganic materials 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 235000019991 rice wine Nutrition 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- IPQVTOJGNYVQEO-KGFNBKMBSA-N sennoside A Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC2=C1C(=O)C1=C(O)C=C(C(O)=O)C=C1[C@@H]2[C@H]1C2=CC(C(O)=O)=CC(O)=C2C(=O)C2=C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C=CC=C21 IPQVTOJGNYVQEO-KGFNBKMBSA-N 0.000 description 1
- IPQVTOJGNYVQEO-AIFLABODSA-N sennoside B Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC2=C1C(=O)C1=C(O)C=C(C(O)=O)C=C1[C@H]2[C@H]1C2=CC(C(O)=O)=CC(O)=C2C(=O)C2=C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C=CC=C21 IPQVTOJGNYVQEO-AIFLABODSA-N 0.000 description 1
- 229940004991 sennoside b Drugs 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000014860 sensory perception of taste Effects 0.000 description 1
- 206010040560 shock Diseases 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 210000005070 sphincter Anatomy 0.000 description 1
- GOLXNESZZPUPJE-UHFFFAOYSA-N spiromesifen Chemical compound CC1=CC(C)=CC(C)=C1C(C(O1)=O)=C(OC(=O)CC(C)(C)C)C11CCCC1 GOLXNESZZPUPJE-UHFFFAOYSA-N 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229960005453 strychnine Drugs 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 208000008281 urolithiasis Diseases 0.000 description 1
- 230000001457 vasomotor Effects 0.000 description 1
- 230000001196 vasorelaxation Effects 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
组别 | 例数 | 痊愈 | 显效 | 好转 | 无效 | 有效率 |
实施例组1 | 42 | 21 | 12 | 7 | 2 | 78.57% |
实施例组2 | 42 | 23 | 11 | 8 | 0 | 80.95% |
对照组 | 42 | 13 | 11 | 11 | 7 | 57.14% |
组别 | 例数 | 第1-2个月 | 第3-4个月 | 第5-6个月 | 第7-18个月 |
实施例组1 | 33 | 8(24.2%) | 15(45.5%) | 10(30.3%) | 0(0%) |
实施例组2 | 34 | 9(26.5%) | 16(47.1%) | 9(26.5%) | 0(0%) |
对照组 | 24 | 5(20.8%) | 4(16.7%) | 7(29.2%) | 8(33.3%) |
Claims (5)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510795791.6A CN105233141A (zh) | 2014-04-11 | 2014-04-11 | 用于治疗结核性胸腔积液的药物组合物及其制备方法 |
CN201410145260.8A CN103861017B (zh) | 2014-04-11 | 2014-04-11 | 用于治疗结核性胸腔积液的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410145260.8A CN103861017B (zh) | 2014-04-11 | 2014-04-11 | 用于治疗结核性胸腔积液的中药组合物及其制备方法 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510795791.6A Division CN105233141A (zh) | 2014-04-11 | 2014-04-11 | 用于治疗结核性胸腔积液的药物组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103861017A CN103861017A (zh) | 2014-06-18 |
CN103861017B true CN103861017B (zh) | 2016-05-25 |
Family
ID=50900405
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510795791.6A Withdrawn CN105233141A (zh) | 2014-04-11 | 2014-04-11 | 用于治疗结核性胸腔积液的药物组合物及其制备方法 |
CN201410145260.8A Active CN103861017B (zh) | 2014-04-11 | 2014-04-11 | 用于治疗结核性胸腔积液的中药组合物及其制备方法 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510795791.6A Withdrawn CN105233141A (zh) | 2014-04-11 | 2014-04-11 | 用于治疗结核性胸腔积液的药物组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN105233141A (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1709309A (zh) * | 2005-06-02 | 2005-12-21 | 郑伟达 | 一种治疗水肿病的中药组合物及其制备方法 |
CN101785819A (zh) * | 2010-02-26 | 2010-07-28 | 泰一和浦(北京)中医药研究院有限公司 | 一种治疗胸积水的中药组合物及其制备方法 |
CN101940708A (zh) * | 2010-09-14 | 2011-01-12 | 曹锋 | 一种治疗恶性胸腔积液的中药药剂 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102614376B (zh) * | 2012-04-09 | 2013-09-11 | 孙毅 | 一种治疗结核性胸腔积液的中药汤剂 |
CN103520432B (zh) * | 2013-09-16 | 2015-02-11 | 王帅华 | 一种治疗气滞血瘀型腰椎间盘突出的中药及制备方法 |
-
2014
- 2014-04-11 CN CN201510795791.6A patent/CN105233141A/zh not_active Withdrawn
- 2014-04-11 CN CN201410145260.8A patent/CN103861017B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1709309A (zh) * | 2005-06-02 | 2005-12-21 | 郑伟达 | 一种治疗水肿病的中药组合物及其制备方法 |
CN101785819A (zh) * | 2010-02-26 | 2010-07-28 | 泰一和浦(北京)中医药研究院有限公司 | 一种治疗胸积水的中药组合物及其制备方法 |
CN101940708A (zh) * | 2010-09-14 | 2011-01-12 | 曹锋 | 一种治疗恶性胸腔积液的中药药剂 |
Also Published As
Publication number | Publication date |
---|---|
CN103861017A (zh) | 2014-06-18 |
CN105233141A (zh) | 2016-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103638250B (zh) | 一种治疗面神经麻痹的中药制剂及其制备方法 | |
CN105597071A (zh) | 用于治疗仔猪缺铁性贫血的中药组合物及其制备方法 | |
CN104663989A (zh) | 一种安神茶及其制备方法 | |
CN104642678A (zh) | 一种女士养颜安神茶及其制备方法 | |
CN104206595A (zh) | 一种降脂降糖的地骨皮保健茶及其制备方法 | |
CN109223886A (zh) | 用于健脾止泻的中药组合物及其制备方法和用途 | |
CN104706976A (zh) | 一种治疗失眠的益气安神中药剂及制备方法 | |
CN107898989A (zh) | 一种治疗阻塞性睡眠呼吸暂停综合征的中药组合物及其制备方法 | |
CN103861017B (zh) | 用于治疗结核性胸腔积液的中药组合物及其制备方法 | |
CN105535587A (zh) | 一种治疗心肾不交型心悸失眠的中药制剂及其制备方法 | |
CN104940696A (zh) | 一种治疗肝经湿热型小儿遗尿的药物及其制备方法 | |
CN106110218B (zh) | 一种抗癌痛止痛贴及其制备方法 | |
CN104352866A (zh) | 一种治疗火毒伤津型烧伤的中药制剂及其制备方法 | |
CN104258224A (zh) | 一种治疗肺肾阴虚型慢性支气管炎的五味子口服液及其制备方法 | |
CN103520644B (zh) | 用于治疗痰瘀型高脂血症的中药组合物及其制备方法 | |
CN104223062B (zh) | 一种降压降糖的地骨皮保健口服液及其制备方法 | |
CN103520684A (zh) | 一种降血糖的中药复合物 | |
CN103536879A (zh) | 一种治疗糖尿病的药物组合物以及制备方法 | |
CN104206597B (zh) | 一种缓解肺肾阴虚症状的五味子保健茶及其制备方法 | |
CN103202964A (zh) | 益脑安神药酒 | |
CN105267815A (zh) | 一种治疗小儿肺肾两虚型哮喘的喷雾剂及其制备方法 | |
CN104922542A (zh) | 一种治疗脾肺气虚型小儿遗尿的药物及其制备方法 | |
CN104013850A (zh) | 用于缓解放化疗后全身乏力的药物组合物及其制备方法 | |
CN104474440A (zh) | 用于治疗仔猪营养不良性贫血的药物组合物及其制备方法 | |
CN104800546A (zh) | 一种治疗风湿性心脏病的中药制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Yu Xirong Inventor after: Zhang Zhaoqin Inventor before: Hu Haibo |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160425 Address after: 266200 Shandong province Qingdao City, Pingxiang Road No. 22 atrium Mountain District 6 Building 3 unit 401 Applicant after: Liu Mei Address before: 264006 Yantai, Yantai economic and Technological Development Zone, Zhujianglu Road,,, Career Technical College Applicant before: Hu Haibo |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP02 | Change in the address of a patent holder |
Address after: No.10 diaopu Industrial Park, Gaogang District, Taizhou City, Jiangsu Province 225300 Patentee after: Liu Mei Address before: 266200 Shandong province Qingdao City, Pingxiang Road No. 22 atrium Mountain District 6 Building 3 unit 401 Patentee before: Liu Mei |
|
CP02 | Change in the address of a patent holder | ||
CP02 | Change in the address of a patent holder |
Address after: 266011 Room 401, unit 3, building 6, Zhongting Shanjing community, 22 Pingxiang Road, Shibei District, Qingdao City, Shandong Province Patentee after: Liu Mei Address before: 225300 No.10, diaopu Industrial Park, Gaogang District, Taizhou City, Jiangsu Province Patentee before: Liu Mei |
|
CP02 | Change in the address of a patent holder | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220908 Address after: Room 1702, Block B, Rongcheng Yungu, No. 57, Keji 3rd Road, High-tech Zone, Xi'an City, Shaanxi Province 710000 Patentee after: Chudu Health Technology Group Co.,Ltd. Address before: 266011 Room 401, unit 3, building 6, Zhongting Shanjing community, 22 Pingxiang Road, Shibei District, Qingdao City, Shandong Province Patentee before: Liu Mei |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Traditional Chinese medicine composition for treating tuberculous pleural effusion and its preparation method Effective date of registration: 20230105 Granted publication date: 20160525 Pledgee: Ankang Finance and Credit Financing Guarantee Co.,Ltd. Xi'an Branch Pledgor: Chudu Health Technology Group Co.,Ltd. Registration number: Y2023610000012 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
CP02 | Change in the address of a patent holder |
Address after: Room 11401, Building 3, Longji Guanlan Mountain, No. 76 Keji Second Road, High tech Zone, Xi'an City, Shaanxi Province, 710000 Patentee after: Chudu Health Technology Group Co.,Ltd. Address before: Room 1702, Block B, Rongcheng Yungu, No. 57, Keji 3rd Road, High-tech Zone, Xi'an City, Shaanxi Province 710000 Patentee before: Chudu Health Technology Group Co.,Ltd. |
|
CP02 | Change in the address of a patent holder | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20240102 Granted publication date: 20160525 Pledgee: Ankang Finance and Credit Financing Guarantee Co.,Ltd. Xi'an Branch Pledgor: Chudu Health Technology Group Co.,Ltd. Registration number: Y2023610000012 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Traditional Chinese medicine composition and preparation method for treating tuberculous pleural effusion Effective date of registration: 20240103 Granted publication date: 20160525 Pledgee: Ankang Finance and Credit Financing Guarantee Co.,Ltd. Xi'an Branch Pledgor: Chudu Health Technology Group Co.,Ltd. Registration number: Y2024610000002 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |